MALCOLM OLIVER: Open Payments
NPI 1730278730 · GREENFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 30 payments from 14 companies in 2025. Trend: 2023 $312 · 2024 $356 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $140 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Novo Nordisk Inc | 3 | $54 |
| Lilly USA, LLC | 3 | $54 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| PFIZER INC. | 2 | $34 |
| Globus Medical, Inc. | 1 | $34 |
| Exact Sciences Corporation | 2 | $31 |
| Phadia US Inc. | 1 | $24 |
Products named: REXULTI, BREZTRI, Ozempic, MOUNJARO, Quviviq, CAPLYTA, PAXLOVID, Senza.
Industry payments across MO — which companies pay providers there.
